MoonLake Immunotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MLTX and other ETFs, options, and stocks.About MLTX
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases.
MLTX Key Statistics
Stock Snapshot
With a market cap of 1.35B, MoonLake Immunotherapeutics(MLTX) trades at $18.37. The stock has a price-to-earnings ratio of -4.72.
During the trading session on 2026-06-04, MoonLake Immunotherapeutics(MLTX) shares reached a daily high of $18.56 and a low of $17.96. At a current price of $18.37, the stock is +2.3% higher than the low and still -1.0% under the high.
Trading volume for MoonLake Immunotherapeutics(MLTX) stock has reached 129.05K, versus its average volume of 777.26K.
The stock's 52-week range extends from a low of $5.95 to a high of $62.75.
The stock's 52-week range extends from a low of $5.95 to a high of $62.75.
Analyst ratings
75%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.